Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Other Non-Current Assets of $13.0 million for Q1 2026, up 1.46% on a QoQ basis from $12.8 million in Q4 2025, and up 5.11% year-over-year from $12.4 million in Q1 2025.
Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $13.0 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 5.11% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (up 5.11% YoY) and the FY2025 annual result came in at $12.8 million, up 15.63% from the prior year.
- Other Non-Current Assets was $13.0 million for Q1 2026 at Bicycle Therapeutics, up from $12.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.8 million in Q2 2025 and bottomed at $4.2 million in Q1 2022.
- A 5-year average of $9.3 million and a median of $9.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 151.69% — and 2024, when it plunged 45.83%.
- Bicycle Therapeutics' Other Non-Current Assets stood at $8.5 million in 2022, then sank by 31.52% to $5.8 million in 2023, then soared by 91.19% to $11.1 million in 2024, then gained by 15.63% to $12.8 million in 2025, then gained by 1.46% to $13.0 million in 2026.
- Business Quant data shows BCYC's Other Non-Current Assets at $13.0 million in Q1 2026, $12.8 million in Q4 2025, and $13.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | 12.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.99 Mn |
| Dec 31, 2025 | 12.81 Mn |
| Sep 30, 2025 | 13.71 Mn |
| Jun 30, 2025 | 13.81 Mn |
| Mar 31, 2025 | 12.36 Mn |
| Dec 31, 2024 | 11.07 Mn |
| Sep 30, 2024 | 9.94 Mn |
| Jun 30, 2024 | 6.58 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 12.15 Mn |
| Mar 31, 2023 | 10.57 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 2.78 Mn |
| Jun 30, 2021 | 2.38 Mn |